UA36835A - Method for embryonic nerve tissue fragments preservation - Google Patents

Method for embryonic nerve tissue fragments preservation

Info

Publication number
UA36835A
UA36835A UA2000020810A UA200020810A UA36835A UA 36835 A UA36835 A UA 36835A UA 2000020810 A UA2000020810 A UA 2000020810A UA 200020810 A UA200020810 A UA 200020810A UA 36835 A UA36835 A UA 36835A
Authority
UA
Ukraine
Prior art keywords
nerve tissue
preservation
tissue fragments
embryonic nerve
medium
Prior art date
Application number
UA2000020810A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Георгій Опанасович Бабійчук
Георгий Афанасьвич Бабийчук
Вікторія Вікторівна Ломако
Виктория Викторовна Ломако
Олександр Володимирович Шило
Александр Владимирович Шило
Original Assignee
Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Институт Проблем Криобиологии И Криомедицины Национальной Академии Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України, Институт Проблем Криобиологии И Криомедицины Национальной Академии Наук Украины filed Critical Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority to UA2000020810A priority Critical patent/UA36835A/en
Publication of UA36835A publication Critical patent/UA36835A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to biology and medicine and can be used for cellular therapy. In a method for embryonal nerve tissue (ENT) fragments storage by placing them into a nutrient solution and holding at 4 °C medium 199 with addition of 10 % of an amniotic fluid is used as the nutrient solution. The medium 199 with the addition of the amniotic fluid provides the conditions, that allow to save functional ENT activity in circumstances of hypotermy for up to 12 days.
UA2000020810A 2000-02-15 2000-02-15 Method for embryonic nerve tissue fragments preservation UA36835A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000020810A UA36835A (en) 2000-02-15 2000-02-15 Method for embryonic nerve tissue fragments preservation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000020810A UA36835A (en) 2000-02-15 2000-02-15 Method for embryonic nerve tissue fragments preservation

Publications (1)

Publication Number Publication Date
UA36835A true UA36835A (en) 2001-04-16

Family

ID=74182840

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000020810A UA36835A (en) 2000-02-15 2000-02-15 Method for embryonic nerve tissue fragments preservation

Country Status (1)

Country Link
UA (1) UA36835A (en)

Similar Documents

Publication Publication Date Title
MXPA02006145A (en) Method for isolation of rna from formalinfixed paraffinembedded tissue specimens.
TNSN06059A1 (en) Use of polypeptides of the cupredoxin family in cancer therapy
BR0210599A (en) Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium
ATE363280T1 (en) USE OF PIOGLITAZONE TO IMPROVE KETOSIS AND ACIDOSE
PL329922A1 (en) Quinoline carboxamides as inhibitors of the tumour necrosis factor and of phosphodiesterase
DK1242578T3 (en) Cell culture medium containing growth factors and L-glutamine
GB0127942D0 (en) Needleless injector drug capsule and a method for filing thereof
DE69635924D1 (en) INSULATION AND BREEDING OF MOMENTS
WO2001085910A3 (en) Agents that modulate dna-pk activity and methods of use thereof
Jones et al. Activated macrophages digest the extracellular matrix proteins produced by cultured cells
WO2001095717A3 (en) Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution
EP1269840A4 (en) Method of preserving tissue equivalent and tissue equivalent preserved in frozen state
EP1640449A4 (en) Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line
DE59009945D1 (en) AGENT FOR INHIBITING HIV PROTEASES.
WO2003033678A3 (en) Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
CN111100838B (en) Low-temperature preservation and transportation culture medium
MX2022007910A (en) Temperature-based transient delivery of zscan4 nucleic acids and proteins to cells and tissues.
UA36835A (en) Method for embryonic nerve tissue fragments preservation
WO2005056763A3 (en) Process and formulation to improve viability of stored cells and tissue
ATE366803T1 (en) HIGH CYTOKINE PRODUCTION WITH IMPROVED CELL VIABILITY
SE0004872D0 (en) Method for detoxifying a medical solution
WO2002002591A3 (en) Peptides for use in culture media
Bergmann et al. Regarding the general nature of catheptic enzymes
AU2182801A (en) Method for producing adherent animal cells
UA37996A (en) METHOD OF OBTAINING EMBRYONIC NERVOUS TISSUE TRANSPLANT